Home

Yezan Munther Haddadin, Director: Outlook Therapeutics OTLK Buy · Filed 05/27

Trade details

Type
Insider buy
Amount
$14,960
Shares · price
34,000 sh · $0.44 a share
Held after
37,167 sh
Trade date
26/05/26
Filed
26/05/27
Days to filing
1 days

First buy in 2 years

Since the last buy
2.2 years
Last buy
24/03/28
Insiders buying this week
6 insiders
Holding change
+1073.6%

Outlook Therapeutics trades, last 26 weeks

What else happened in Outlook Therapeutics around then

Filed or reported within 30 days of the trade day · 04/26~06/25

Yezan Munther Haddadin's recent trades

  • Yezan Munther Haddadin

    BuyOutlook Therapeutics

    $24.1K

    Filed 06/03

  • Yezan Munther Haddadin

    BuyOutlook Therapeutics

    $22.2K

    Filed 24/03/29

Yezan Munther Haddadin, Director — bought $15K of Outlook Therapeutics OTLK · 34,000 sh @ $0.44 | Whalegun